VINC (OTC)
VINCERX PHARMA INC
$0.012750
+0.000250 (+2.00%)
Prev close: $0.012500
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raquel E. Izumi
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.48M
- Employees
- 42
- P/E (TTM)
- -0.10
- P/B (TTM)
- 0.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-4.20 | $-3.47 | -0.7320 | -21.11% |
|
Sep 2024 (Q3)
|
$-3.40 | $-4.42 | +1.0201 | +23.08% |
|
Jun 2024 (Q2)
|
$-1.00 | $-4.18 | +3.1820 | +76.09% |
|
Mar 2024 (Q1)
|
$-11.60 | $-4.79 | -6.8060 | -141.97% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.67M |
| Operating Expenses | $27.32M |
| Operating Income/Loss | -$27.32M |
| Income/Loss From Continuing Operations After Tax | -$22.65M |
| Income/Loss From Continuing Operations Before Tax | -$22.65M |
| Net Income/Loss | -$22.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$16.84 |
| Diluted Earnings Per Share | -$32.52 |
| Basic Average Shares | 10,540 |
| Diluted Average Shares | 54,314 |
| Assets | $4.69M |
| Current Assets | $4.69M |
| Prepaid Expenses | $123.00K |
| Other Current Assets | $4.56M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.62M |
| Current Liabilities | $2.62M |
| Accounts Payable | $2.27M |
| Other Current Liabilities | $351.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $2.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.07M |
| Liabilities And Equity | $4.69M |
| Net Cash Flow From Operating Activities | -$22.84M |
| Net Cash Flow From Operating Activities, Continuing | -$22.84M |
| Net Cash Flow From Investing Activities | -$6.90M |
| Net Cash Flow From Investing Activities, Continuing | -$6.92M |
| Net Cash Flow From Financing Activities | $21.84M |
| Net Cash Flow From Financing Activities, Continuing | $21.84M |
| Exchange Gains/Losses | $114.00K |
| Net Cash Flow | -$7.77M |
| Net Cash Flow, Continuing | -$7.88M |
| Comprehensive Income/Loss | -$22.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.54M |
| Other Comprehensive Income/Loss | -$9.54M |